{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T17:47:29Z","timestamp":1773596849845,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017160","name":"Beni-Suef University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.taap.2026.117759","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T07:14:26Z","timestamp":1771226066000},"page":"117759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Interference with IL-13\/JAK1\/STAT6 inflammatory signaling by dipalmitoyl phosphoethanolamine-polyethylene glycol (DPPE-PEG); A CD1d-dependent antagonist to iNKT cells; contributes to retarding the advancement of oxazolone colitis"],"prefix":"10.1016","volume":"510","author":[{"given":"Esraa Abdel-Nassir","family":"Abdel-Razek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba M.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany A.","family":"Azouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.117759_bb0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10787-023-01362-2","article-title":"Management of ulcerative colitis by dichloroacetate: impact on NFATC1\/NLRP3\/IL1B signaling based on bioinformatics analysis combined with in vivo experimental verification","volume":"32","author":"Abdel-Razek","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.taap.2026.117759_bb0010","first-page":"1543","article-title":"Dipalmitoyl-phosphoethanolamine exhibits anti-colitis effect that involves down-regulation of IL-13 inflammatory cytokine by CD1d antagonism and iNK-T cells inactivation","volume":"48","author":"AbdElRazik","year":"2025","journal-title":"Bull. Pharm. Sci. Assiut Univ."},{"key":"10.1016\/j.taap.2026.117759_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrgastro.2014.201","article-title":"Molecular pathways controlling barrier function in IBD","volume":"12","author":"Atreya","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2026.117759_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23046","article-title":"Renoprotective effect of vinpocetine against ischemia\/reperfusion injury: modulation of NADPH oxidase\/Nrf2, IKK\u03b2\/NF-\u03baB p65, and cleaved caspase-3 expressions","volume":"36","author":"Azouz","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.taap.2026.117759_bb0025","series-title":"Theory and practice of histological techniques","author":"Bancroft","year":"2008"},{"key":"10.1016\/j.taap.2026.117759_bb0030","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/febs.15238","article-title":"NKT cells and the regulation of intestinal immunity: a two-way street","volume":"287","author":"Brailey","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.taap.2026.117759_bb0035","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2021.01.044","article-title":"The role of myeloperoxidase and neutrophil extracellular traps in the pathogenesis of inflammatory bowel disease","volume":"160","author":"Chami","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2026.117759_bb0040","first-page":"238","article-title":"Clinicopathologic study of dextran sulfate sodium experimental murine colitis","volume":"69","author":"Cooper","year":"1993","journal-title":"Lab. Investig.; J. Tech. Methods Pathol."},{"key":"10.1016\/j.taap.2026.117759_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2013.06.007","article-title":"Involvement of JAK\/STAT signaling in the pathogenesis of inflammatory bowel disease","volume":"76","author":"Coskun","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2026.117759_bb0050","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/ecco-jcc\/jjx003","article-title":"The future of Janus kinase inhibitors in inflammatory bowel disease","volume":"11","author":"De Vries","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"10.1016\/j.taap.2026.117759_bb0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/08923973.2021.1878214","article-title":"Metformin alleviates inflammation in oxazolone induced ulcerative colitis in rats: plausible role of sphingosine kinase 1\/sphingosine 1 phosphate signaling pathway","volume":"43","author":"El-Mahdy","year":"2021","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.taap.2026.117759_bb0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.bjp.0701396","article-title":"Anti-inflammatory activity of cationic lipids","volume":"122","author":"Filion","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2026.117759_bb0065","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/mi.2008.40","article-title":"The role of IL-13 and NK T cells in experimental and human ulcerative colitis","volume":"1","author":"Fuss","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.taap.2026.117759_bb0070","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI19836","article-title":"Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis","volume":"113","author":"Fuss","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2026.117759_bb0075","series-title":"Invariant Natural Killer T Cells (iNkt) in Alternaria-Induced Type 2 Innate Lung Inflammation: Reciprocal Interactions with ILC2","author":"Garc\u00eda","year":"2022"},{"key":"10.1016\/j.taap.2026.117759_bb0080","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.autrev.2019.03.012","article-title":"The role of interleukin-13 in chronic inflammatory intestinal disorders","volume":"18","author":"Giuffrida","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.taap.2026.117759_bb0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1074-7613(02)00453-3","article-title":"Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells","volume":"17","author":"Heller","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.taap.2026.117759_bb0090","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","article-title":"Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution","volume":"129","author":"Heller","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2026.117759_bb0095","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1038\/mi.2008.46","article-title":"Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function","volume":"1","author":"Heller","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.taap.2026.117759_bb0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00535-005-1744-3","article-title":"Novel pathophysiological concepts of inflammatory bowel disease","volume":"41","author":"Hibi","year":"2006","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.taap.2026.117759_bb0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fcimb.2018.00395","article-title":"Targeting IL-13 as a host-directed therapy against ulcerative colitis","volume":"8","author":"Hoving","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.taap.2026.117759_bb0110","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1136\/gutjnl-2016-313208","article-title":"Interleukin 13-mediated colitis in the absence of IL-4R\u03b1 signalling","volume":"66","author":"Hoving","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.taap.2026.117759_bb0115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/jcm11020400","article-title":"The role of innate and adaptive immune cells in the pathogenesis and development of the inflammatory response in ulcerative colitis","volume":"11","author":"Ka\u0142u\u017cna","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.taap.2026.117759_bb0120","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/imm.12319","article-title":"Therapeutic activity of an interleukin-4\/interleukin-13 dual antagonist on oxazolone-induced colitis in mice","volume":"143","author":"Kasaian","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.taap.2026.117759_bb0125","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.3390\/ijms23169344","article-title":"Inflammatory bowel disease: a review of pre-clinical murine models of human disease","volume":"23","author":"Katsandegwaza","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.117759_bb0130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3892\/or.2012.2185","article-title":"Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model","volume":"29","author":"Kee","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2026.117759_bb0135","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcmgh.2015.01.006","article-title":"Experimental models of inflammatory bowel diseases","volume":"1","author":"Kiesler","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2026.117759_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4110\/in.2017.17.1.25","article-title":"Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies","volume":"17","author":"Kim","year":"2017","journal-title":"Immune Netw."},{"key":"10.1016\/j.taap.2026.117759_bb0145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1254\/jphs.FP0040214","article-title":"Oxazolone-induced colitis in BALB\/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis","volume":"96","author":"Kojima","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.taap.2026.117759_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2018.08.010","article-title":"Natural killer T cells and ulcerative colitis","volume":"335","author":"Lai","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.taap.2026.117759_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1343718","article-title":"Role of CD1d and iNKT cells in regulating intestinal inflammation","volume":"14","author":"Lee","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.taap.2026.117759_bb0160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1158\/2326-6066.CIR-16-0168","article-title":"Lack of STAT6 attenuates inflammation and drives protection against early steps of colitis-associated colon cancer","volume":"5","author":"Leon-Cabrera","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.taap.2026.117759_bb0165","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/cvr\/cvv259","article-title":"A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE\u2212\/\u2212 mice by reducing lesion necrosis and inflammation","volume":"109","author":"Li","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.taap.2026.117759_bb0170","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.taap.2026.117759_bb0175","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.4049\/jimmunol.0901208","article-title":"A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity","volume":"184","author":"Lombardi","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2026.117759_bb0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00005373-198602000-00008","article-title":"Lack of correlation between decreased chemotaxis and susceptibility to infection in burned rats","volume":"26","author":"Manktelow","year":"1986","journal-title":"J. Trauma"},{"key":"10.1016\/j.taap.2026.117759_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197487","article-title":"Functional characterization of oxazolone-induced colitis and survival improvement by vagus nerve stimulation","volume":"13","author":"Meroni","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2026.117759_bb0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00365521.2016.1235224","article-title":"Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications","volume":"52","author":"Muthas","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.taap.2026.117759_bb0195","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1084\/jem.182.5.1281","article-title":"Antibodies to interleukin 12 abrogate established experimental colitis in mice","volume":"182","author":"Neurath","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.taap.2026.117759_bb0200","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1080\/00365520701409035","article-title":"Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis","volume":"42","author":"Olsen","year":"2007","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.taap.2026.117759_bb0205","series-title":"Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Cinical Perspectives","first-page":"149","article-title":"Targeting the STAT6 signaling pathway as a therapy against colon cancer","author":"Rugeles","year":"2021"},{"key":"10.1016\/j.taap.2026.117759_bb0210","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.3390\/molecules25225230","article-title":"Alleviation of ulcerative colitis potentially through th1\/th2 cytokine balance by a mixture of rg3-enriched Korean red ginseng extract and persicaria tinctoria","volume":"25","author":"Saba","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2026.117759_bb0215","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3389\/fphys.2018.00890","article-title":"Nanotherapeutics for treatment of pulmonary arterial hypertension","volume":"9","author":"Segura-Ibarra","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.taap.2026.117759_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00999","article-title":"Invariant natural killer T cells shape the gut microbiota and regulate neutrophil recruitment and function during intestinal inflammation","volume":"9","author":"Shen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.taap.2026.117759_bb0225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.32734\/sumej.v4i2.5523","article-title":"Chemically-induced colitis models in animal","volume":"4","author":"Siregar","year":"2021","journal-title":"Sumatera Med. J."},{"key":"10.1016\/j.taap.2026.117759_bb0230","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.taap.2026.117759_bb0235","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jgr.2021.07.001","article-title":"Restorative effects of Rg3-enriched Korean red ginseng and Persicaria tinctoria extract on oxazolone-induced ulcerative colitis in mice","volume":"46","author":"Ullah","year":"2022","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.taap.2026.117759_bb0240","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00011-021-01482-x","article-title":"Targeting JAK\/STAT signaling pathways in treatment of inflammatory bowel disease","volume":"70","author":"Wang","year":"2021","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.taap.2026.117759_bb0245","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2621.1996.tb14713.x","article-title":"Proteins as potential endpoint temperature indicators for ground beef patties","volume":"61","author":"Wang","year":"1996","journal-title":"J. Food Sci."},{"key":"10.1016\/j.taap.2026.117759_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2022.12888","article-title":"Pulsatilla decoction alleviates colitis by enhancing autophagy and regulating PI3K-Akt-mTORC1 signaling pathway","volume":"25","author":"Wang","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.taap.2026.117759_bb0255","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1084\/jem.20072484","article-title":"The transcription factor NFATc2 controls IL-6\u2013dependent T cell activation in experimental colitis","volume":"205","author":"Weigmann","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.taap.2026.117759_bb0260","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.taap.2026.117759_bb0265","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.taap.2026.117759_bb0270","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/abbs\/gmaa044","article-title":"Effect of TrkB-PLC\/IP3 pathway on intestinal inflammatory factors and enterocyte apoptosis in mice with colitis","volume":"52","author":"Xu","year":"2020","journal-title":"Acta Biochim. Biophys. Sin."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T16:49:43Z","timestamp":1773593383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":54,"alternative-id":["S0041008X26000554"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117759","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interference with IL-13\/JAK1\/STAT6 inflammatory signaling by dipalmitoyl phosphoethanolamine-polyethylene glycol (DPPE-PEG); A CD1d-dependent antagonist to iNKT cells; contributes to retarding the advancement of oxazolone colitis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117759"}}